Use of neurofilament-light chain (NfL) in the management of patients with multiple sclerosis

June 27, 2024

Recommend to a Colleague print

 

Summarizes recent guidance on the use of NfL in clinical practice. Includes management algorithms published by Freedman et al. eBioMedicine 2024;101:104970.

8 slides

Download the slide deck

Recommend to a Colleague

Related Posts

• MS biomarkers – the year in review
  December 16, 2025
• ECTRIMS 2025 HIGHLIGHTS – SATURDAY, SEPTEMBER 27, 2025
  September 27, 2025
• ECTRIMS 2025 HIGHLIGHTS – FRIDAY, SEPTEMBER 26, 2025
  September 26, 2025
• ECTRIMS 2025 slide resource
  September 25, 2025
• ECTRIMS 2025 HIGHLIGHTS – THURSDAY, SEPTEMBER 25, 2025
  September 25, 2025

Go back to home page